164 related articles for article (PubMed ID: 32670734)
1. Multifactorial Pulmonary Hypertension in Systemic Sclerosis.
Hussain H; Espinosa R; Chittivelu S
Cureus; 2020 Jul; 12(7):e9144. PubMed ID: 32670734
[TBL] [Abstract][Full Text] [Related]
2. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic Sclerosis.
Moinzadeh P; Bonella F; Oberste M; Weliwitage J; Blank N; Riemekasten G; Müller-Ladner U; Henes J; Siegert E; Günther C; Kötter I; Pfeiffer C; Schmalzing M; Zeidler G; Korsten P; Susok L; Juche A; Worm M; Jandova I; Ehrchen J; Sunderkötter C; Keyßer G; Ramming A; Schmeiser T; Kreuter A; Lorenz HM; Hunzelmann N; Kreuter M
Chest; 2024 Jan; 165(1):132-145. PubMed ID: 37582424
[TBL] [Abstract][Full Text] [Related]
3. Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.
Almaaitah S; Highland KB; Tonelli AR
Integr Blood Press Control; 2020; 13():15-29. PubMed ID: 32280271
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.
Shahane A
Rheumatol Int; 2013 Jul; 33(7):1655-67. PubMed ID: 23334373
[TBL] [Abstract][Full Text] [Related]
5. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
[TBL] [Abstract][Full Text] [Related]
6. Systemic Sclerosis and Pulmonary Disease.
Ngo K
Adv Exp Med Biol; 2021; 1303():173-182. PubMed ID: 33788193
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
[TBL] [Abstract][Full Text] [Related]
8. The burden of comorbidities in pulmonary arterial hypertension.
Lang IM; Palazzini M
Eur Heart J Suppl; 2019 Dec; 21(Suppl K):K21-K28. PubMed ID: 31857797
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines.
Dinarti LK; Anggrahini DW; Lilyasari O; Siswanto BB; Hartopo AB
Glob Heart; 2021 Apr; 16(1):23. PubMed ID: 34040936
[TBL] [Abstract][Full Text] [Related]
10. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
[TBL] [Abstract][Full Text] [Related]
11. Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.
Valenzuela A; Nandagopal S; Steen VD; Chung L
Rheum Dis Clin North Am; 2015 Aug; 41(3):489-506. PubMed ID: 26210131
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.
Rachdi I; Tougorti M; Daoud F; Aydi Z; Zoubeidi H; Ben Dhaou B; Boussema F
Ann Cardiol Angeiol (Paris); 2019 Oct; 68(4):221-225. PubMed ID: 30685083
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary veno-occlusive disease: a probably underdiagnosed cause of pulmonary hypertension in systemic sclerosis.
Duarte AC; Cordeiro A; Loureiro MJ; Ferreira F
Clin Rheumatol; 2020 May; 39(5):1687-1691. PubMed ID: 31965379
[TBL] [Abstract][Full Text] [Related]
14. The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease.
Zanatta E; Marra MP; Famoso G; Balestro E; Giraudo C; Calabrese F; Rea F; Doria A
Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145263
[TBL] [Abstract][Full Text] [Related]
15. The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis.
Lee MH; Bull TM
F1000Res; 2019; 8():. PubMed ID: 32025283
[TBL] [Abstract][Full Text] [Related]
16. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL
Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742
[TBL] [Abstract][Full Text] [Related]
17. Systemic Sclerosis with Multiple Pulmonary Manifestations.
Kotnur MR; Suresh P; Reddy VS; Sharma T; Salim NA
J Clin Diagn Res; 2016 Jun; 10(6):OD16-7. PubMed ID: 27504339
[TBL] [Abstract][Full Text] [Related]
18. Systemic scleroderma: Review and updated approach and case description to addressing pulmonary arterial hypertension and idiopathic pulmonary fibrosis: A dual challenge in treatment.
Cueto-Robledo G; Tovar-Benitez D; Alfaro-Cruz A; Gonzalez-Hermosillo LM
Curr Probl Cardiol; 2024 Apr; 49(4):102404. PubMed ID: 38232920
[TBL] [Abstract][Full Text] [Related]
19. Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis.
Maurer B; Reich N; Juengel A; Kriegsmann J; Gay RE; Schett G; Michel BA; Gay S; Distler JH; Distler O
Ann Rheum Dis; 2012 Aug; 71(8):1382-7. PubMed ID: 22523431
[TBL] [Abstract][Full Text] [Related]
20. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
Jimenez SA; Piera-Velazquez S
Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
